Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders??? Equity

v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Preferred Stock
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2024 $ 40 $ 124 $ 35,465,504 $ (30,976,066) $ 4,489,602
Balance (in Shares) at Dec. 31, 2024 39,810 123,968      
Shares issued for conversion of convertible loans and interest $ 3 47,280 47,283
Shares issued for conversion of convertible loans and interest (in Shares) 3,665      
Shares issued for legal settlement $ 13 148,397 148,410
Shares issued for legal settlement (in Shares) 12,750      
Issuance of warrants in conjunction with convertible loans 1,385,000 1,385,000
Net loss (476,303) (476,303)
Balance at Mar. 31, 2025 $ 40 $ 140 37,046,181 (31,452,369) 5,593,992
Balance (in Shares) at Mar. 31, 2025 39,810 140,383      
Balance at Dec. 31, 2025 $ 40 $ 1,055 42,571,572 (35,420,175) 7,152,492
Balance (in Shares) at Dec. 31, 2025 39,810 1,055,412      
Shares issued for conversion of convertible loans and interest $ 8 42,849 42,857
Shares issued for conversion of convertible loans and interest (in Shares) 8,172      
Shares issued for the exercise of warrants $ 4 15,498 15,502
Shares issued for the exercise of warrants (in Shares) 3,334      
Stock based compensation 12,404 12,404
Net loss (173,767) (173,767)
Balance at Mar. 31, 2026 $ 40 $ 1,067 $ 42,642,323 $ (35,593,942) $ 7,049,488
Balance (in Shares) at Mar. 31, 2026 39,810 1,066,918